No abstract available
Publication types
-
Comment
-
Comparative Study
-
Editorial
MeSH terms
-
Community-Acquired Infections / drug therapy
-
Community-Acquired Infections / mortality
-
Community-Acquired Infections / prevention & control
-
Critical Care / methods
-
Critical Illness / mortality
-
Critical Illness / therapy
-
Female
-
Hospital Mortality / trends
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Intensive Care Units
-
Male
-
Pneumonia, Bacterial / drug therapy*
-
Pneumonia, Bacterial / mortality
-
Pneumonia, Bacterial / prevention & control
-
Prognosis
-
Risk Assessment
-
Role
-
Sepsis / drug therapy*
-
Sepsis / mortality
-
Sepsis / prevention & control
-
Survival Analysis
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors